Ying Wu

发表

Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.

M. Pirmohamed, B. K. Park, D. Naisbitt, 2007, The Journal of allergy and clinical immunology.

Vaccine-Elicited 10-Kilodalton Culture Filtrate Protein-Specific CD8+ T Cells Are Sufficient To Mediate Protection against Mycobacterium tuberculosis Infection

S. Behar, Ying Wu, S. Morris, 2008, Infection and Immunity.

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

S. Behar, Ying Wu, J. Woodworth, 2007, Expert review of vaccines.

Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base.

M. Pirmohamed, D. Basketter, D. Naisbitt, 2008, The Journal of investigative dermatology.

Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial

Yuemiao Zhang, Xupu Ma, Ying Wu, 2022, eClinicalMedicine.

Anti-Idiotypic Regulatory Responses Induced by Vaccination with DNA Encoding Murine TCR Vα5 and Vβ2

Xiaojun Xu, P. Lv, Yan Zhang, 2007 .

Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo1

S. Behar, Ying Wu, J. Woodworth, 2008, The Journal of Immunology.

HIV: current opinion in escapology.

P. Klenerman, R. Phillips, Ying Wu, 2002, Current opinion in microbiology.

Activation of T cells by carbamazepine and carbamazepine metabolites.

M. Pirmohamed, B. K. Park, D. Naisbitt, 2006, The Journal of allergy and clinical immunology.

Protection In Vivo Cells Require Perforin to Kill Target Cells T +-Specific CD 8 Mycobacterium tuberculosis

S. Behar, Ying Wu, J. Woodworth, 2008 .